ctrl K

Watchlist Price Alert

Carmell Therapeutics Corp... (CTCX)

NASDAQ: CTCX · Real-Time Price · USD

0.20

0.01 (2.77%)

At close: Mar 07, 2025, 3:55 PM

Carmell Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a
Cost of Revenue	124.79K	242.56K	n/a
Gross Profit	-124.79K	-242.56K	n/a
Operating Income	-5.22M	-5.51M	-1.94M
Interest Income	n/a	2.25M	8.09K
Pretax Income	-16.21M	-9.05M	-6.48M
Net Income	-15.45M	-9.05M	-6.48M
Selling & General & Admin	2.6M	3.22M	863.33K
Research & Development	2.5M	2.2M	982.84K
Other Expenses	n/a	10.92K	37.38K
Operating Expenses	5.09M	5.51M	1.94M
Interest Expense	889.32K	3.75M	2.5M
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	5.22M	5.51M	1.94M
Income Tax Expense	-760.16K	391.2K	2.54M
Shares Outstanding (Basic)	11.02M	19.77M	19.77M
Shares Outstanding (Diluted)	11.02M	19.77M	19.77M
EPS (Basic)	-1.46	-0.46	-0.33
EPS (Diluted)	-1.46	-0.46	-0.33
EBITDA	-15.19M	-5.25M	-1.66M
EBIT	-15.32M	-5.3M	-329.38K
Depreciation & Amortization	124.79K	242.56K	242.12K